Loading term…
Inspection of manufacturing and/or clinical sites conducted by the regulatory authority before approving an application (e.g. NDA, BLA, MAA) to verify data and compliance.
FDA may inspect the commercial manufacturing site and key clinical sites before granting approval to ensure data integrity and GMP readiness.
FDA PAI Program, EMA pre-authorisation inspections
Not being inspection-ready: missing validation, incomplete batch records, or inadequate quality systems.
How did you prepare for the pre-approval inspection? Show validation and batch documentation.